Cite
Association of Serum Hepatitis B Virus RNA With Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Under Nucleos(t)ide Analogues Therapy.
MLA
Liu, Shi, et al. “Association of Serum Hepatitis B Virus RNA With Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Under Nucleos(t)Ide Analogues Therapy.” Journal of Infectious Diseases, vol. 226, no. 5, Sept. 2022, pp. 881–90. EBSCOhost, https://doi.org/10.1093/infdis/jiab597.
APA
Liu, S., Deng, R., Zhou, B., Liang, X., Liu, Z., Peng, J., Chen, J., Zhou, Y., Guo, Y., Chen, Y., Li, W., Shen, S., Lu, X., Zhao, S., Liao, X., Liang, H., Lan, Y., Hou, J., Fan, R., & Sun, J. (2022). Association of Serum Hepatitis B Virus RNA With Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Under Nucleos(t)ide Analogues Therapy. Journal of Infectious Diseases, 226(5), 881–890. https://doi.org/10.1093/infdis/jiab597
Chicago
Liu, Shi, Rui Deng, Bin Zhou, Xieer Liang, Zhihong Liu, Jie Peng, Jinjun Chen, et al. 2022. “Association of Serum Hepatitis B Virus RNA With Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Under Nucleos(t)Ide Analogues Therapy.” Journal of Infectious Diseases 226 (5): 881–90. doi:10.1093/infdis/jiab597.